Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085108 · ClinicalTrials.gov registry record
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 130
- Enrollment target
NCT03085108 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 130 participants.
The verdict
NCT03085108 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The main purpose of this cross-sectional study is to generate data to support the psychometric properties of the Suicide Ideation and Behavior Assessment Tool (SIBAT) and validate its use in participants at imminent risk of suicide.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2017-03-31 |
| Est. Completion | 2017-11-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03085108
The ClinicalTrials.gov registry entry for NCT03085108 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT03085108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03085108 about?
NCT03085108 is a clinical study titled "A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment". The main purpose of this cross-sectional study is to generate data to support the psychometric properties of the Suicide Ideation and Behavior Assessment Tool (SIBAT) and validate its use in participants at imminent risk of suicide.
What is the current status of trial NCT03085108?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2017-03-31. Estimated completion is 2017-11-14.
What interventions are being tested in trial NCT03085108?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT03085108?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.